Nuvalent
Price & Volume
Stats
See more52W Range | $55.53-$112.88 |
Market Cap | $7.6B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$5.33 |
News
See moreYahoo Finance • 5 days ago
FDA accepts NDA for Nuvalent's zidesamtinib for non-small cell lung cancer
Yahoo Finance • 5 days ago
Biotech Stock Gets Booted in Latest Fund Update
Yahoo Finance • 7 days ago
Nuvalent Announces Public Offering of Common Stock
Yahoo Finance • 3 months ago
Nuvalent’s SWOT analysis: oncology innovator’s stock faces pivotal year
About
CEO | Dr. James R. Porter Ph.D. |
CFO | Ms. Alexandra Balcom C.P.A., M.B.A. |
Address | One Broadway, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 218 |
